AI assistant
Sending…
DEXCOM INC — Director's Dealing 2012
Dec 14, 2012
30198_dirs_2012-12-14_d0495da2-8a8a-4453-81a5-919201cfbbad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2012-12-12
Reporting Person: VALDES JORGE A (CTO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-12 | Common Stock | S | 4122 | $14.2923 | Disposed | 27750 | Indirect |
| 2012-12-13 | Common Stock | S | 4811 | $14.1 | Disposed | 22939 | Indirect |
| 2012-12-13 | Common Stock | S | 22939 | $14 | Disposed | 0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 153323 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $14.29 to $14.30. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares are held by Jorge A. Valdes and Suzanne Lopez-Calleja, Joint Tenants.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17